Shelton, CT-based spinal device developer Spine Wave has raised $17.6 million in debt financing, according to an SEC filing. The company said in a press release that previous investor New Enterprise Associates led the financing, which also included Morgenthaler Ventures, Compass Global Fund, New Leaf Venture Partners, Canaan Partners, Foundation Medical Partners, and Memphis Implant Partners. Spine Wave said it plans to use the proceeds of the financing to fund commercial operations and additional clinical trials of its injected spinal treatment called “NuCore” for patients with degenerative disc disease.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
